WallStSmart

Akso Health Group ADR (AHG)vsQuipt Home Medical Corp (QIPT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Quipt Home Medical Corp generates 1685% more annual revenue ($264.97M vs $14.84M). AHG leads profitability with a 0.0% profit margin vs -0.0%. QIPT earns a higher WallStSmart Score of 40/100 (D).

AHG

Avoid

16

out of 100

Grade: F

Growth: 6.0Profit: 2.5Value: 6.0Quality: 7.5
Piotroski: 2/9Altman Z: 7.29

QIPT

Hold

40

out of 100

Grade: D

Growth: 5.3Profit: 2.5Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AHGUndervalued (+19.4%)

Margin of Safety

+19.4%

Fair Value

$1.75

Current Price

$2.20

$0.45 discount

UndervaluedFair: $1.75Overvalued
QIPTUndervalued (+78.7%)

Margin of Safety

+78.7%

Fair Value

$16.68

Current Price

$3.65

$13.03 discount

UndervaluedFair: $16.68Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHG2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
7.2910/10

Safe zone — low bankruptcy risk

QIPT1 strengths · Avg: 8.0/10
Price/BookValuation
1.6x8/10

Reasonable price relative to book value

Areas to Watch

AHG4 concerns · Avg: 3.8/10
Price/BookValuation
9.6x4/10

Trading at 9.6x book value

Revenue GrowthGrowth
0.9%4/10

0.9% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.83B3/10

Smaller company, higher risk/reward

QIPT4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
0.3%4/10

0.3% revenue growth

Market CapQuality
$162.30M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

Return on EquityProfitability
-0.1%2/10

ROE of -0.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : AHG

The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.

Bull Case : QIPT

The strongest argument for QIPT centers on Price/Book.

Bear Case : AHG

The primary concerns for AHG are Price/Book, Revenue Growth, EPS Growth.

Bear Case : QIPT

The primary concerns for QIPT are Revenue Growth, Market Cap, Operating Margin.

Key Dynamics to Monitor

AHG profiles as a value stock while QIPT is a turnaround play — different risk/reward profiles.

QIPT carries more volatility with a beta of 0.49 — expect wider price swings.

AHG is growing revenue faster at 0.9% — sustainability is the question.

QIPT generates stronger free cash flow (7M), providing more financial flexibility.

Bottom Line

QIPT scores higher overall (40/100 vs 16/100). AHG offers better value entry with a 19.4% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Akso Health Group ADR

HEALTHCARE · MEDICAL DISTRIBUTION · China

Akso Health Group ADR is a leading entity in the healthcare sector, focused on delivering innovative medical solutions and comprehensive patient care services. The company utilizes advanced health technologies to exploit burgeoning opportunities in telehealth and personalized medicine, supported by a strong emphasis on research and development. With a solid business model and a highly proficient workforce, Akso Health Group represents a compelling investment opportunity for institutional investors looking to capitalize on the dynamic changes within the healthcare industry.

Visit Website →

Quipt Home Medical Corp

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.

Want to dig deeper into these stocks?